Trial intelligence / Profile preview

Nebido in male type 2 diabetics with symptomatic testosterone deficiency

2008-000931-16Phase 4Unknown

Sponsor
Dr G I Hackett
Start
Mar 2008
Countries
1
01

Overview

Phase 4 trial of testosterone undecanoate in type 2 diabetes mellitus (T2DM) and Hypogonadism, sponsored by Dr G I Hackett. Primary endpoint: Primary Efficacy measures. Status: unknown.

02

Drugs

testosterone undecanoate
03

Conditions

type 2 diabetes mellitus (T2DM)Hypogonadism

Beyond the preview

Go deeper on 2008-000931-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000931-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call